Real Regulatory to virtually attend 2nd Joint DIA-EUCOPE Workshop on ATMPs, Innovative Gene and Cell Therapies
Will you be virtually joining us at the DIA-EUCOPE Workshop on ATMPs, Innovative Gene and Cell Therapies?
The 2nd Joint DIA-EUCOPE Workshop on ATMPs, Innovative Gene and Cell Therapies is a unique opportunity to hear directly from the Industry and Regulatory representatives about the challenges, opportunities and political implications of advanced therapies. This workshop will include a wide range of topics that will help you and your team make more informed decisions on regulatory strategies and evidence packages – as well as market access challenges – which are key topics for cell and gene therapy developers.
In an entirely virtual meeting format, both speakers and attendees will be participating remotely via a digital platform. For more info, visit this link.
Our expert, Dorothée Fouchier, will be casting in. Chat to her about how we can help you with your regulatory strategy and support creation of your submission package.
Contact us today to arrange a meeting at a time that suits your schedule. We look forward to meeting you at this very unique event!
Attendees: Dorothée Fouchier
Dorothée joined the company in May 2006 and has worked in regulatory affairs since 2003 mainly in human medicinal product, including small chemical entity and biotechnology products. Previously Dorothée was part of the CMC regulatory team at the manufacturing site of a major pharmaceutical company.
Dorothée’s current role is as Managing Consultant of the Irish office.
As part of the management team Dorothee has managed projects through the full product lifecycle from early development to product maintenance and MAH compliance. She has also supported several clients in preparation of inspection readiness. Dorothée oversees and manages our Irish office whilst providing expert consultancy to her client projects.